Clinical studies reveal elevated serum soluble transferrin receptor (sTfR) levels positively correlating with inflammatory markers in RA patients, despite paradoxically low systemic iron levels, suggesting systemic iron redistribution [37]. The gene discussed is TFRC; the disease is rheumatoid arthritis.